(Total Views: 302)
Posted On: 11/28/2022 10:05:50 AM
Post# of 51

$AXSM News Article - Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer's Disease Agitation https://marketwirenews.com/news-releases/axso...62907.html


My Twitter: WhyteStocks